Poly Medicure Ltd

Poly Medicure Ltd Share Price Today: Live Updates & Key Insights

Get insights on Poly Medicure Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Poly Medicure Ltd Share Price Chart

Poly Medicure Ltd Fundamentals

Traded Volume: 38,734

Market Cap(Cr): 19,024

Avg Traded Price 1876.05

1 Year return -27.51%

Upper Circuit 1,891.7

Lower Circuit 1,865.2

P/E TTM 53.00

P/B Ratio 36.00

Traded Value(Cr) 727.00

EPS TTM 35.713

Book value 35.713

Dividend 0.00%

Poly Medicure Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Poly Medicure Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Poly Medicure Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -4.19%

1M -0.13%

3M -4.57%

1Y -27.51%

YTD -29.88%

Poly Medicure Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Poly Medicure Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 63970.00

Day Before Yesterday 78939.00

1W Avg 64744.00

1M Avg 2.61L

3M Avg 2.09L

Poly Medicure Ltd Technical Details

Poly Medicure Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1864

Support 2 1851

Support 3 1838

Pivot Point : 1878

Resistance 1 1891

Resistance 2 1904

Resistance 3 1917

Poly Medicure Ltd Corporate Actions

Poly Medicure Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Poly Medicure Ltd’s capital allocation strategies.

All

Ex-Date 18-Sep-2025 Type D Description 3.50/share@70.00% Record Date 18-Sep-2025 Ratio 70.00

Ex-Date 19-Sep-2024 Type D Description 3.00/share@60.00% Record Date - Ratio 60.00

Ex-Date 21-Sep-2023 Type D Description 3.00/share@60.00% Record Date - Ratio 60.00

Ex-Date 16-Sep-2022 Type D Description 2.50/share@50.00% Record Date 19-Sep-2022 Ratio 50.00

Ex-Date 16-Sep-2021 Type D Description 2.50/share@50.00% Record Date 17-Sep-2021 Ratio 50.00

Ex-Date 27-Feb-2020 Type D Description 2.00/share@40.00% Record Date 29-Feb-2020 Ratio 40.00

Ex-Date 13-Sep-2019 Type D Description 2.00/share@40.00% Record Date - Ratio 40.00

Ex-Date 18-Sep-2018 Type D Description 2.00/share@40.00% Record Date - Ratio 40.00

Ex-Date 20-Sep-2017 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00

Ex-Date 24-Mar-2017 Type B Description share@1:1 Record Date 28-Mar-2017 Ratio 1:1

Ex-Date 15-Feb-2017 Type D Description 1.00/share@20.00% Record Date 16-Feb-2017 Ratio 20.00

Ex-Date 11-Nov-2016 Type D Description 1.00/share@20.00% Record Date 15-Nov-2016 Ratio 20.00

Ex-Date 19-Sep-2016 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00

Ex-Date 17-Mar-2016 Type D Description 2.50/share@50.00% Record Date 18-Mar-2016 Ratio 50.00

Ex-Date 18-Sep-2015 Type D Description 2.50/share@50.00% Record Date - Ratio 50.00

Ex-Date 02-Feb-2015 Type S Description share@1:2.00 Record Date 03-Feb-2015 Ratio 1:2.00

Ex-Date 15-Sep-2014 Type D Description 4.00/share@40.00% Record Date - Ratio 40.00

Ex-Date 19-Sep-2013 Type D Description 2.00/share@20.00% Record Date - Ratio 20.00

Ex-Date 09-Jul-2013 Type B Description share@1:1 Record Date 10-Jul-2013 Ratio 1:1

Ex-Date 13-Sep-2012 Type D Description 3.00/share@30.00% Record Date - Ratio 30.00

Ex-Date 25-Aug-2011 Type D Description 3.00/share@30.00% Record Date - Ratio 30.00

Ex-Date 24-Aug-2010 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 26-Mar-2010 Type B Description share@1:1 Record Date 29-Mar-2010 Ratio 1:1

Ex-Date 21-Aug-2009 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00

Ex-Date 23-Aug-2007 Type D Description 2.50/share@25.00% Record Date - Ratio 25.00

Dividends

Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 70

Announcement Date 19-Sep-2024 Ex Dividend Date 19-Sep-2024 Dividend(%) 60

Announcement Date 21-Sep-2023 Ex Dividend Date 21-Sep-2023 Dividend(%) 60

Announcement Date 16-Sep-2022 Ex Dividend Date 16-Sep-2022 Dividend(%) 50

Announcement Date 16-Sep-2021 Ex Dividend Date 16-Sep-2021 Dividend(%) 50

Announcement Date 27-Feb-2020 Ex Dividend Date 27-Feb-2020 Dividend(%) 40

Announcement Date 13-Sep-2019 Ex Dividend Date 13-Sep-2019 Dividend(%) 40

Announcement Date 18-Sep-2018 Ex Dividend Date 18-Sep-2018 Dividend(%) 40

Announcement Date 20-Sep-2017 Ex Dividend Date 20-Sep-2017 Dividend(%) 10

Announcement Date 15-Feb-2017 Ex Dividend Date 15-Feb-2017 Dividend(%) 20

Announcement Date 11-Nov-2016 Ex Dividend Date 11-Nov-2016 Dividend(%) 20

Announcement Date 19-Sep-2016 Ex Dividend Date 19-Sep-2016 Dividend(%) 10

Announcement Date 17-Mar-2016 Ex Dividend Date 17-Mar-2016 Dividend(%) 50

Announcement Date 18-Sep-2015 Ex Dividend Date 18-Sep-2015 Dividend(%) 50

Announcement Date 15-Sep-2014 Ex Dividend Date 15-Sep-2014 Dividend(%) 40

Announcement Date 19-Sep-2013 Ex Dividend Date 19-Sep-2013 Dividend(%) 20

Announcement Date 13-Sep-2012 Ex Dividend Date 13-Sep-2012 Dividend(%) 30

Announcement Date 25-Aug-2011 Ex Dividend Date 25-Aug-2011 Dividend(%) 30

Announcement Date 24-Aug-2010 Ex Dividend Date 24-Aug-2010 Dividend(%) 25

Announcement Date 21-Aug-2009 Ex Dividend Date 21-Aug-2009 Dividend(%) 25

Announcement Date 23-Aug-2007 Ex Dividend Date 23-Aug-2007 Dividend(%) 25

Bonus

Record Date 28-Mar-2017 Ex-Bonus Date 24-Mar-2017 Ratio 1:1

Record Date 10-Jul-2013 Ex-Bonus Date 09-Jul-2013 Ratio 1:1

Record Date 29-Mar-2010 Ex-Bonus Date 26-Mar-2010 Ratio 1:1

Splits

Record Date 03-Feb-2015 Split Date 02-Feb-2015 Face Value (Before/After) 10.00/5.00

Others

Rights No Rights has been declared by POLYMED

Poly Medicure Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Poly Medicure Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Poly Medicure Ltd's relative performance and valuation against major competitors.

Stock Name Poly Medicure Ltd ₹1876.90 (-0.12%) M. Cap (Cr) 190.24 1 Yr Return (%) -27.51% P/E (TTM) 52.56 PB Ratio 7.34

Stock Name Medplus Health Services Ltd ₹767.40 (-1.79%) M. Cap (Cr) 91.95 1 Yr Return (%) +4.32% P/E (TTM) 47.14 PB Ratio 5.28

Stock Name Laxmi Dental Ltd ₹296.35 (+0.51%) M. Cap (Cr) 16.29 1 Yr Return (%) NaN% P/E (TTM) 62.63 PB Ratio 22.51

Stock Name Vasa Denticity Ltd ₹601.30 (-0.14%) M. Cap (Cr) 10.42 1 Yr Return (%) -7.07% P/E (TTM) 58.90 PB Ratio 8.33

Stock Name Nureca Ltd ₹254.90 (-1.81%) M. Cap (Cr) 2.55 1 Yr Return (%) -6.99% P/E (TTM) 62.07 PB Ratio 1.31

Stock Name Bilcare Ltd ₹78.35 (-4.04%) M. Cap (Cr) 1.84 1 Yr Return (%) +45.60% P/E (TTM) -14.53 PB Ratio 0.39

Stock Name Raaj Medisafe India Ltd ₹84.00 (+3.70%) M. Cap (Cr) 1.11 1 Yr Return (%) -2.34% P/E (TTM) 14.36 PB Ratio 4.11

Poly Medicure Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Poly Medicure Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 236.65 Mar 2024 256.10 Mar 2023 194.86 Mar 2022 126.26 Mar 2021 116.40

PARTICULARS Investing Activities Mar 2025 -1191.17 Mar 2024 -237.02 Mar 2023 -187.22 Mar 2022 -88.71 Mar 2021 -434.41

PARTICULARS Financing Activities Mar 2025 952.93 Mar 2024 -17.32 Mar 2023 -7.89 Mar 2022 -39.71 Mar 2021 318.92

PARTICULARS Net Cash Flow Mar 2025 -1.59 Mar 2024 1.76 Mar 2023 -0.25 Mar 2022 -2.16 Mar 2021 0.90

Poly Medicure Ltd Shareholding Pattern

This shows the ownership breakdown of Poly Medicure Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 62.42%

Public 14.28%

Other Institutions 5.49%

FII 9.77%

Mutual Funds 8.04%

About Poly Medicure Ltd

Poly Medicure Limited was incorporated on March 30, 1995. The Company is a manufacturer/producer of Medical Devices. It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Company's product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It currently operate 10 manufacturing facilities across India, China, Egypt and Italy. In India, it operate 7 manufacturing facilities, four of which are situated at Faridabad (Haryana), and 2 in Jaipur (Rajasthan) and 1 in Haridwar (Uttarakhand). It operate 1 manufacturing facility in China through its wholly owned subsidiary Poly Medicure (Laiyang) Company Limited.The Company started commercial production by April' 97 with an installed capacity of Medical Disposables (16500000 Nos ) and Cold/Hot Therapy Packs (500000 Nos).During the year 1997-98, the company produced 51.06 lac nos. of Medical Disposables which constitute 42.60% of the installed capacity utilisation. The company exported products of the value Rs. 50.28 lacs. The Company has been registered as an ISO 9002 company by SGS Yarsley International Certification Service Limited, United Kingdom.During the year 2003, the Company entered into a Joint Venture arrangement for putting up a plant in Egypt for manufacturing of various Medical Disposables. It has subscribed to 23% (6,90,000 Egyptian Pounds equivalent to Rs. 71,07,000/-) of the share capital of the Joint Venture Entity. The Overseas Joint Venture is expected to commence commercial production during the current financial year.During the year 2005, it expanded installed capacity from 1000 lacs nos. to 1200 lacs nos. of Medical Disposables. The Company successfully implemented Quality Management System and has been accredited by SGS Yarsley International Certification Services, United Kingdom with ISO 9001:2000, ISO 13488:1996 and CE mark for some of its products. For the rest of the products, it has been accredited CE mark by DNV, Norway thus making the entire product range match up to International Quality Standards.In 2008, the Company's manufacturing unit located at Haridwar, Uttarakhand commenced its commercial operations.In 2010, the Company received Silver Patent Award by Department of Pharmaceutical Ministry of Chemicals and Fertilizers, Government of India and Pharmaceuticals Export Promotion Council in recognition of commendable contribution in Medical devices patent Category. It was also awarded by India Brand Equity Foundation (IBEF), in certificate of excellence in recognition of exemplary growth and sustainable success. As of March 31, 2015, Company had over 100 varieties of disposable medical devices, including veterinary disposable devices. In 2015, the manufacturing facility in Jaipur, Rajasthan commenced commercial operations.During the year 2018, the Company's wholly owned subsidiary, Poly Medicure B.V. Netherlands acquired 82% stake in Plan 1 Health s.r.l., an Italy-based manufacturing company. Apart from this, it started manufacturing operations of new plant at IIT, in Faridabad effective from 28th February, 2018.The Company received Top Exporter Award by The Plastics Export Promotion Council, Dept of Commerce, Govt. of India, Star Performer Award by EEPC India Regional Award (Northern) for Export Excellence, Dare to Dream Award by ZEE Business in the category of emerging Company of the year and Export Excellence Award by FIA (Faridabad Industries Association), Haryana for the year 2018-19. The Company received the Medical Device Company of the Year 2018, award from Department of Pharmaceuticals, Government of India - Biggest recognition and Achievement since inception of the company. The award was conferred based on Company's export performance, R&D efforts and New Product launches. It was awarded Industrial Innovation Award by Confederation of Indian Industries (CII) on 18th December, 2019 for securing place among the top 25 innovative companies in 2019.The Company received the Forbes Asia Best under a Billion Award in 2020 as the region's top 200 small and mid-sized companies. The Company currently operate eight manufacturing facilities across India, China, Egypt and Italy. In India, it operate five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand). In addition, it is in the process of expanding the manufacturing capacities at facilities situated in Faridabad (Haryana) and Jaipur (Rajasthan). Apart from this, the Company operate one manufacturing facility in China through its wholly-owned subsidiary Poly Medicure (Liayang) Company Limited that is certified to be compliant with Korea Good Manufacturing Practices by the Korea Food and Drug Administration, Ministry of Food and Drug Safety and has been accredited with a EC certificate for quality assurance system and EN ISO 13485:2016 for its quality management system. In addition, it operates one manufacturing facility in Assuit, Egypt, through our associate Ultra for Medical Products that is accredited with EC certificates or quality assurance system. It operate one manufacturing facility in Italy through step-down subsidiary Plan1 Health S.R.L., which is accredited with EC certification for quality assurance system and EN 13485:2016 for its quality management system by DEKRA Certification B.V. Netherlands.The Company use different technologies for manufacturing different medical devices, including injection molding, extrusion, insert molding, blow molding, ultrasonic welding, UV bonding and laser welding and has expertise in handling different kind of specialized plastic materials. The manufacturing of components takes place on highly advanced PLC controlled plastic injection molding machines by using hot runner system or runner less mold technology, which is a clean technology and generates minimal scrap. Tubes are produced on highly accurate extruders with good yield. Its assembly machines are built-in with poka-yoke features and vision inspection systems. The manufacturing facility is equipped with CNC controlled machines which enable accurate and efficient control over fabrication of molds. It further employ kaizen or lean manufacturing technology for cycle time reduction in various manufacturing processes.Its manufacturing process comprises of using raw materials in molding or tubing through extruders, following which components are assembled and samples are tested. The products are packed using a blister packing machine in duplex or correlated boxes and the final products undergo sterilization and quality checks. These include, automated arms installed at assembly machines, which are designed and programmed for specific assembly functions that may be deployed for various product variants. The manufacturing equipment is also supported by `Servo' systems that enable precise machine movements that improves accuracy in processes and limits generation of scrap.The Company operate the R&D Centre at Faridabad, Haryana which is approved by DSIR. Our R&D efforts are primarily focused on developing new products within existing product verticals as well as introduce products to enter into new product verticals, particularly focusing on fluid management within non-communicable diseases segment, including oncology, nephrology and cardiology, and further improving existing processes and production cost efficiency. As of March 31, 2021, the Company had over 130 SKUs of medical devices. Besides this, it supplied products to over 110 countries, in Europe, Africa, Americas, Australia, and Asia through a network of over 220 distributors in these jurisdictions. The Company's Indian and International manufacturing facilities have been accredited with several international quality certifications. All manufacturing facilities have been accredited with the EC certificates for quality assurance systems and EN ISO 13485:2016 certifications. Further, Faridabad Facilities and Haridwar Facility, have also been accredited with management system certificates for compliance with ISO 9001:2015.In 2023-24, the Company expanded into cardiology and launched a Critical Care Division for focusing on products used in intensive care. The distribution network with a pan-India presence included 506 distributors in 2024. The Company set up 2 new manufacturing units in Faridabad, Haryana and Jaipur in Rajasthan, by expanding its existing Faridabad Facility III and Jaipur I Facility in FY 2025.

Chairman & Independent Director

Devendra Raj Mehta

Registered office Property No 232B 3rd Floor, Okhla Indl Estate Phase-III, New Delhi, New Delhi, 110020

FAX :91-11-26321838/81/89/93

Background

Incorporation Year 1995

Face Value ₹5.00

Market Lot 1

Poly Medicure Ltd Latest News

VIEW MORE NEWS

FAQs on Poly Medicure Ltd